Plexin B2 could promote skin inflammation, as well as keratinocyte proliferation in psoriasis vulgaris; therefore, it may be used as a targeted therapy for psoriasis treatment [15]. This evidence concerns the gene PLXNB2 and psoriasis vulgaris.